Research
The Division of Urogynecology and Pelvic Reconstructive Surgery is leading the way with a diverse range of research, in both basic science and clinical trials. Our research focuses on innovative technology and therapies for women suffering from pelvic floor disorders.
The Stanford Program for Urologic Research (SPUR) studies conditions of the bladder, including urinary incontinence, Overactive Bladder, Radiated Bladder, and Non-compliant Bladder. SPUR also studies the pathophysiology of stem cell related treatments using new animal models.
Clinical research in the Division of Urogynecology focuses on studying pelvic organ prolapse, incontinence, genitourinary syndrome of menopause and overactive bladder. We are involved in large, multi-center trials throughout the U.S., as well as physician-initiated trials.
Contact Us
For more information about any current or past research projects or inquiries about potential collaboration or participation, please phone: (650) 725-6079
Recruiting
Lessening Incontinence through Low-impact Activity (LILA)
The purpose of this study is to evaluate the efficacy of group based intervention for urinary incontinence in ambulatory middle-aged and older women and explore potential mediators of intervention effects in this population.
Principal Investigator: Leslee L. Subak, MD
CELLEBRATE: An Adaptive, Two Stage, Double-Blind, Stratified, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence
The purpose of this study is to evaluate the safety and efficacy of the study product in treating stress urinary incontinence (SUI) (accidental loss of urine due to physical activity, such as laughing, coughing, sneezing). Treatment with study product involves a medical procedure in which your own muscle cells are collected, processed and then injected into the tissues of your urinary passage. It is believed these cells become part of the tissue where they have been injected. This study will determine if the cells are safe and effective in treating SUI in adult females.
Principal Investigator: Eric R. Sokol, MD